Clinical Trial Detail

NCT ID NCT04157985
Title Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Antoinette J Wozniak
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Ipilimumab

Pembrolizumab

Atezolizumab

Age Groups: senior adult

No variant requirements are available.